Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | E-40-016 |
Topic: | Functional Neuromuscular Electrical Stimulation (NMES) |
Section: | Durable Medical Equipment |
Effective Date: | November 30, 2015 |
Issue Date: | August 6, 2018 |
Last Reviewed: | July 2018 |
Functional neuromuscular electrical stimulation (NMES) involves the use of a device that transmits electrical impulse to the skin over selected muscle groups by way of electrodes. There are two categories of NMES. One is used to treat muscle atrophy and stimulates the muscle when the individual is in a resting state. The other, also known as functional electrical stimulation (FES), is used to enhance functional activity of neurologically impaired and spinal cord injured (SCI) patients. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Use for Walking in Patients with Spinal Cord Injury (SCI)
A functional electrical stimulator (FES) for SCI (e.g, Parastep® Ambulation System) may be considered medically necessary for individuals with a diagnosis of paraplegia and who meet ALL of the following criteria:
In addition to meeting the above criteria, individuals with SCI must have completed a training program which consists of physical medicine sessions with the device, (Parastep® Ambulation System) over a period of three (3) months. The trial period will enable the physician treating the individual for his or her SCI to properly evaluate the person's ability to use these devices frequently and for the long term. These physical medicine sessions are only covered in the following settings: inpatient hospital, outpatient hospital, comprehensive outpatient rehabilitation facilities, and outpatient rehabilitation facilities. The physical medicine necessary to perform this training must be directly performed by the physical therapist as part of a one-on-one training program; this service cannot be done unattended.
The goal of physical medicine must be to train SCI patients on the use of the FES device to achieve walking, not to reverse or retard muscle atrophy.
FES for SCI patients is considered not medically necessary and, therefore, not covered for individuals with ANY ONE of the following absolute contraindications:
FES is considered experimental/investigational for all FES devices except for the Parastep System; scientific evidence does not demonstrate the efficacy of other systems.
Coverage is subject to any applicable physical medicine and/or durable medical equipment (DME) limitation in the member's benefit contract.
Treatment of Muscle Atrophy
Functional neuromuscular electrical stimulation (NMES) may be considered medically necessary for treatment of disuse atrophy where nerve supply to the muscle is intact, including brain, spinal cord and peripheral nerves, and other non-neurological reasons for disuse are causing atrophy. Some examples would be casting or splinting of a limb, contracture due to scarring of soft tissue as in burn lesions, and hip replacement surgery (until orthotic training begins).
Supplies
Supplies for NMES may be considered medically necessary when annual documentation is noted in the patient’s medical record.
Place of Service: Inpatient/Outpatient |
Experimental/Investigational (E/I) services are not covered regardless of place of service.
NMES is typically an outpatient procedure which is only eligible for coverage as an inpatient procedure in special circumstances, including, but not limited to, the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.
The policy position applies to all commercial lines of business |
Denial Statements |
Services that do not meet the criteria of this policy will not be considered medically necessary. A network provider cannot bill the member for the denied service unless: (a) the provider has given advance written notice, informing the member that the service may be deemed not medically necessary; (b) the member is provided with an estimate of the cost; and (c) the member agrees in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Services that do not meet the criteria of this policy will be considered experimental/investigational (E/I). A network provider can bill the member for the experimental/investigational service. The provider must give advance written notice informing the member that the service has been deemed E/I. The member must be provided with an estimate of the cost and the member must agree in writing to assume financial responsibility in advance of receiving the service. The signed agreement must be maintained in the provider’s records.
Links |